Identification of long stress-induced non-coding transcripts that have altered expression in cancer.

[1]  C. Wahlestedt,et al.  Non-coding RNA transcripts: Sensors of neuronal stress, modulators of synaptic plasticity, and agents of change in the onset of Alzheimer's disease , 2009, Neuroscience Letters.

[2]  D. Coppola,et al.  Nicotine Promotes Tumor Growth and Metastasis in Mouse Models of Lung Cancer , 2009, PloS one.

[3]  J. Mattick.  The Genetic Signatures of Noncoding RNAs , 2009, PLoS genetics.

[4]  M. Crespi,et al.  Novel long non-protein coding RNAs involved in Arabidopsis differentiation and stress responses. , 2008, Genome research.

[5]  S. Woodson,et al.  The rpoS mRNA leader recruits Hfq to facilitate annealing with DsrA sRNA. , 2008, RNA.

[6]  Chia-Lun Tsai,et al.  Higher order chromatin structure at the X-inactivation center via looping DNA. , 2008, Developmental biology.

[7]  Eugene Berezikov,et al.  Piwi and piRNAs act upstream of an endogenous siRNA pathway to suppress Tc3 transposon mobility in the Caenorhabditis elegans germline. , 2008, Molecular cell.

[8]  T. Morgan,et al.  Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of β-secretase , 2008, Nature Medicine.

[9]  Hong-Gang Li,et al.  [A novel class of testis-specific small RNAs: piRNAs]. , 2008, Zhonghua nan ke xue = National journal of andrology.

[10]  W. Filipowicz,et al.  Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? , 2008, Nature Reviews Genetics.

[11]  George A Calin,et al.  MicroRNAs and cancer: Profile, profile, profile , 2007, International journal of cancer.

[12]  A. Kibel,et al.  SnoRNA U50 is a candidate tumor-suppressor gene at 6q14.3 with a mutation associated with clinically significant prostate cancer. , 2007, Human molecular genetics.

[13]  A. Kibel,et al.  SnoRNA U 50 is a candidate tumor-suppressor gene at 6 q 14 . 3 with a mutation associated with clinically significant prostate cancer , 2008 .

[14]  H. Wang,et al.  Precancerous model of human breast epithelial cells induced by NNK for prevention , 2008, Breast Cancer Research and Treatment.

[15]  Howard Y. Chang,et al.  Functional Demarcation of Active and Silent Chromatin Domains in Human HOX Loci by Noncoding RNAs , 2007, Cell.

[16]  William Stafford Noble,et al.  Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project , 2007, Nature.

[17]  M. Gerstein,et al.  What is a gene, post-ENCODE? History and updated definition. , 2007, Genome research.

[18]  K. Fukamachi,et al.  Possible Application of Human c-Ha-ras Proto-Oncogene Transgenic Rats in a Medium-Term Bioassay Model for Carcinogens , 2007, Toxicologic pathology.

[19]  K. Tsuneyama,et al.  High-density oligonucleotide microarrays and functional network analysis reveal extended lung carcinogenesis pathway maps and multiple interacting genes in NNK [4-(methylnitrosamino)-1-(3-pyridyle)-1-butanone] induced CD1 mouse lung tumor , 2006, Journal of Cancer Research and Clinical Oncology.

[20]  Clifford A. Meyer,et al.  Model-based analysis of tiling-arrays for ChIP-chip , 2006, Proceedings of the National Academy of Sciences.

[21]  Helen Pearson,et al.  Genetics: What is a gene? , 2006, Nature.

[22]  J. Mattick,et al.  Non-coding RNA. , 2006, Human molecular genetics.

[23]  N. Tran,et al.  Regulation of apoptosis by a prostate-specific and prostate cancer-associated noncoding gene, PCGEM1. , 2006, DNA and cell biology.

[24]  C. Chuang,et al.  Synergistic DNA damage and lipid peroxidation in cultured human white blood cells exposed to 4‐(methyl‐nitrosamino)‐1‐(3‐pyridyl)‐1‐butanone and ultraviolet A , 2006, Environmental and molecular mutagenesis.

[25]  F. Costa,et al.  Non-coding RNAs: new players in eukaryotic biology. , 2005, Gene.

[26]  L. Kemény,et al.  Identification and Characterization of a Novel, Psoriasis Susceptibility-related Noncoding RNA gene, PRINS* , 2005, Journal of Biological Chemistry.

[27]  E. Bissonnette,et al.  4‐(Methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanone, a component of tobacco smoke, modulates mediator release from human bronchial and alveolar epithelial cells , 2005, Clinical and experimental immunology.

[28]  V. Moulton.  Tracking down noncoding RNAs. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[29]  L. Loeb,et al.  Environmental and chemical carcinogenesis. , 2004, Seminars in cancer biology.

[30]  A. Geirsson,et al.  Inhibition of alloresponse by a human trophoblast non-coding RNA suppressing class II transactivator promoter III and major histocompatibility class II expression in murine B-lymphocytes. , 2004, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[31]  Michael Thomas,et al.  MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancer , 2003, Oncogene.

[32]  Terence P. Speed,et al.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..

[33]  K. Davies,et al.  Characterization of adapt33, a stress-inducible riboregulator. , 2003, Gene expression.

[34]  Jan Barciszewski,et al.  Beyond the proteome: non-coding regulatory RNAs , 2002, Genome Biology.

[35]  E. Dmitrovsky,et al.  Evidence for the epidermal growth factor receptor as a target for lung cancer prevention. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[36]  S. Eddy.  Non–coding RNA genes and the modern RNA world , 2001, Nature Reviews Genetics.

[37]  S. Amin,et al.  Coexposure to ethanol with N-nitrosodimethylamine or 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone during lactation of rats: marked increase in O(6)-methylguanine-DNA adducts in maternal mammary gland and in suckling lung and kidney. , 2000, Toxicology and applied pharmacology.

[38]  S. Hecht,et al.  DNA adduct formation from tobacco-specific N-nitrosamines. , 1999, Mutation research.

[39]  D. Hatsukami,et al.  Quantitation of 4-oxo-4-(3-pyridyl)butanoic acid and enantiomers of 4-hydroxy-4-(3-pyridyl)butanoic acid in human urine: A substantial pathway of nicotine metabolism. , 1999, Chemical research in toxicology.

[40]  L. Gierasch,et al.  Domain interactions in E. coli SRP: stabilization of M domain by RNA is required for effective signal sequence modulation of NG domain. , 1997, Molecular cell.

[41]  S. C. Lakhotia,et al.  What is a gene? , 1997 .

[42]  H. Bartsch,et al.  Tobacco-specific nitrosamines , 1996, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[43]  S. Hecht,et al.  The biological significance of tobacco-specific N-nitrosamines: smoking and adenocarcinoma of the lung. , 1996, Critical reviews in toxicology.

[44]  J. Wehland,et al.  IrpA , is highly homologous to monocytogenesPrfA-regulated gene in Listeria Identification and characterization of a novel , 1996 .

[45]  H. Schuller,et al.  DNA single-strand breaks and toxicity induced by 4-(methyl-nitrosamino)-1-(3- pyridyl)-1-butanone or N-nitrosodimethylamine in hamster and rat liver. , 1994, Carcinogenesis.

[46]  S. Hecht,et al.  Metabolites of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in smokers' urine. , 1993, Cancer research.

[47]  J. Brugge.  Origins of human cancer : a comprehensive review , 1991 .

[48]  S. Hecht,et al.  Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. , 1988, Carcinogenesis.

[49]  A. Wallace.  Meyer's Exploration of New Guinea , 1873, Nature.